Better Coronavirus Stock: AstraZeneca vs. Pfizer

Comparing AstraZeneca (NASDAQ: AZN) and Pfizer (NYSE: PFE) would have been a much different exercise just one year ago. However, things have changed significantly for both drugmakers in 2020 because of the COVID-19 pandemic.

Both AstraZeneca and Pfizer rank among the leaders in the race to develop a safe and effective COVID-19 vaccine. So far this year, AstraZeneca has delivered better returns for investors. But which is the better coronavirus stock now? Here's how AstraZeneca and Pfizer stack up against each other.

Image source: Getty Images.

Continue reading

Source Fool.com